Disease-Free Survival is a Promising Surrogate for Overall Survival in Colorectal Cancer Studies

Affiliations

¹ Division of Biostatistics, Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Editorial

Jeffrey S Morris. J Natl Cancer Inst. 2022.

. 2022 Jan 11;114(1):5-6.

doi: 10.1093/jnci/djab188.

¹ Division of Biostatistics, Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

No abstract available

Comment on

Reevaluating Disease-Free Survival as an Endpoint vs Overall Survival in Stage III Adjuvant Colon Cancer Trials.
Yin J, Salem ME, Dixon JG, Jin Z, Cohen R, DeGramont A, Van Cutsem E, Taieb J, Alberts SR, Wolmark N, Schmoll HJ, Saltz LB, George TJ, Goldberg RRM, Kerr R, Lonardi S, Yoshino T, Yothers G, Grothey A, Andre T, Shi Q. Yin J, et al. J Natl Cancer Inst. 2022 Jan 11;114(1):60-67. doi: 10.1093/jnci/djab187. J Natl Cancer Inst. 2022. PMID: 34505880 Free PMC article.

1. Yin J, Salem ME, Dixon JG, Jin Z, et al. Reevaluating disease-free survival as an endpoint vs overall survival in stage III adjuvant colon cancer trials. J Nat Cancer Inst. 2021. doi: 10.1093/jnci/djab187. - PMC - PubMed